A survey of UK-based screening and surveillance practices for carcinoid heart disease in patients with neuroendocrine tumours
{{output}}
Symptoms of carcinoid heart disease (CHD) can be subtle or absent even in advanced disease; therefore screening for CHD is important in the management of neuroendocrine tumours (NETs). Previous data in 2015 demonstrated variation in screening practices in the ... ...
